Clinolipid (lipid injectable emulsion)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 ADVERSE REACTIONS Post-marketing Experience Immune System Disorders: Hypersensitivity with the manifestations of rash...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts